European Diabetes Leadership Forum Participation Report
date : 4/26/2012
This forum was held as a meeting for high-level discussions on how diabetes control could act as a model case for progression in the area of chronic disease control. It aimed to reflect on the magnitude of the influence of diabetes prevalence in Europe, and hold discussions from the perspective of prevention, early detection, and improvement of treatment. The forum was organized by the Organization for Economic Co-operation and Development (OECD) together with the Danish Diabetes Association (DDA), with backing from the Danish government and Danish Health Ministry and support from the company Novo Nordisk. Around 760 people attended, with participants representing government, industry, academia, and patients present from all over the world, including EU Member States, European Free Trade Association Member States, EU non-member states, and OECD Member States.
Speeches were also made by the Danish Prime Minister and Minister of Health and Welfare, as well as Kofi Annan, former U.N. Secretary-General. The importance of comprehensive approaches which transcend health policy frameworks was emphasized, together with the importance of policies which bridge patient and multi-stakeholder involvement in prevention with treatment. Furthermore, it was also re-recognized that diabetes control does not just end with the formulation of a road map as actual implementation is also important, and to this end patient empowerment and cooperative activities between different sectors were highlighted as being additionally important.
Exhibition date:2012-04-26
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Dementia Project “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (April 27, 2026)
- [Publication Report] Future of the Healthcare System Project “Policy roadmaps for acting early on NCDs” (March, 2026)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-05-15
[Registration Open] (Webinar) The 2nd J-PEP Seminar – A New Framework for Providing Information on Clinical Trial Participant Recruitment – Legal Points to Consider from the Perspective of Meaningful Involvement (June 15, 2026)
-
2026-05-18
[Registration Open] Kick-off Panel Discussion “From Japan and Africa, in Discussion with the World: Cultivating Together a Philosophical Dialogue on Health” (June 15, 2026)
-
2026-05-19
[Registration Open] (Webinar) HGPI Special Seminar “Building a Society Where People Live with Blood Disorders: The Future of Blood Disorder Policy as Examined from the Frontlines of Home-Based Care × Lived Experience Research” (June 12, 2026)



